FDA OKs Atlas Stent System, Wearables in Epilepsy Monitoring, and ASA Policy Statement on Stroke Care Systems


Neurology News Network for the week ending May 25, 2019.

This week, Neurology News Network covered the FDA approval of Neuroform's Atlas Stent System for wide-neck intracranial aneurysms, the effectiveness of wearable epilepsy monitoring devices has been evaluated, and the new American Stroke Association's policy statement on updating stroke systems of care. (Transcript below).


Welcome to Neurology News Network. I’m Jenna Payesko. Let’s get into the news from this week.

Stryker announced that the FDA granted premarket approval to its Neuroform Atlas Stent System for the treatment of wide-neck, intracranial aneurysms in conjunction with embolic detachable coils. The approval was backed by data from the ATLAS IDE trial, which proved the efficacy of the device.

It was previously approved under a Humanitarian Device Exemption, restricting its use to specific hospitals with approval.

Automated systems and devices may have the ability to provide a wearable, out-of-hospital seizure diagnostic monitoring method for patients with epilepsy, suggest findings from a recent study. Data showed that there was no significant difference between classification results, whether the diagnosis was from the automated method or standard inpatient video EEG monitoring.

The automated system detected epileptic seizures and psychogenic non‐epileptic seizures with a sensitivity of 72.7% and specificity of 100%. The positive and negative predictive values for PNES classification were 81.3% and 100%, respectively.

In light of recent advances in scientific knowledge and innovations in clinical care in stroke systems, the American Stroke Association published a policy statement to help guide policymakers and public healthcare agencies in updating stroke systems of care to reflect these advances, translating these developments into improvements in patient outcomes and facilitating optimal stroke care delivery.

The recommendations include early and primary prevention, acute stroke recognition and activation of emergency medical services, triage to appropriate facilities, the designation of treatment at stroke centers, secondary prevention at hospital discharge, and rehabilitation and recovery.

For more direct access to expert insight, head to neurologylive.com. This has been Neurology News Network. Thanks for watching.

Related Videos
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
 Brian G. Weinshenker, MD, FRCP
Kathy Zackowski, PhD, OTR
Eoin P. Flanagan, MB, BCh
© 2024 MJH Life Sciences

All rights reserved.